Thanks Lew, I think it was me and to be honest, I was totally convinced that they wouldn't let us know whether it had been Tovaxin or placebo. Thank you for that information!Loobie wrote:I had a request to ask about the extension study after the Phase IIb for Tovaxin. I don't remember who, but someone asked if we find out about our initial trial and whether or not we were getting the goods.
You hit the nail on the head, who the hell knows for sure?Loobie wrote:Things have slipped a bit in my vision even though everything else seems to be staying on track, so who the hell knows? I just know that short of a major attack, I'm staying in. As I go through this I find myself really wanting to get the drug
I think you know of my interest in treating autoimmunes with parasites? At least with those clinical trials the participants were given the option of continuing treatment as part of a long term safety and effaciacy study which has continued for 6 or 7 years. I think it's fairly common to roll short term trials into long term for treatments which prove effective.Loobie wrote: I could be dead wrong on this, but I don't know that I've ever heard of an open extension on a double blind trial before.
Users browsing this forum: No registered users